The Private Healthcare Exchanges conference July 16-17 in Chicago will focus on how the Affordable Care Act is changing the way insurers sell health insurance.

This meeting will represent a collaboration among academic researchers, clinical researchers, pharmaceutical and biotechnology companies, regulatory and health agencies, patient organizations, payors and venture capital/private equity concerns to address the need for effective therapies for rare diseases.